Our team advised Bank of China the issuance, of ZAR 350 million unsecured floating rate notes on the Interest Rate Market of the JSE

Home
Home
Our team advised Bank of China the issuance, of ZAR 350 million unsecured floating rate notes on the Interest Rate Market of the JSE

Our team advised Bank of China the issuance, of ZAR 350 million unsecured floating rate notes on the Interest Rate Market of the JSE

Cliffe Dekker Hofmeyr represented the Bank of China’s Johannesburg Branch.

1 Jun 2018 1 min read Featured work

Related sectors

Debt Capital Markets
Private Equity

Bank of China is one of the five largest state-owned commercial banks in the People's Republic of China. Our capital markets team advised this prestigious client in the issuance, in December 2017, of ZAR 350 million unsecured floating rate notes on the Interest Rate Market of the JSE. The issuance was made under the Bank of China’s ZAR 15 billion domestic medium term note programme.

You might also be interested in

3 Jun 2026

by Patrick Uaurikirua Kauta and Shereef Martin

Gas commercialisation: The missing link in Namibia’s oil story

A Namibian and South African perspective on the legal, commercial and infrastructure issues that will determine whether offshore discoveries translate into bankable gas value chains.

Oil & Gas

15 min read

25 Aug 2025

by Anja Hofmeyr and Kgatlhiso Mofokeng

Minister issues direction to ICASA on inquiry regarding Individual Electronic Communications Network Services Licences

On 22 August 2025, the Minister of Communications and Digital Technologies issued a policy direction to the Independent Communications Authority of South Africa (ICASA) to conduct an inquiry into the need for applications for Individual Electronic Communications Network Services (ECNS) licences. The policy directive refers to the 2019 Data Service Market Inquiry (DSMI) report and the findings made therein, including the “l ack of effective competitive restraints ” on pricing levels in the market.

Technology & Communications

2 min read

27 May 2026

by Charles Green and Anneri Du Preez

Compounded GLP-1 medicines under sustained scrutiny in South Africa as SAHPRA and SAPC take enforcement action

South Africa’s regulatory stance on compounded Glucagon-like peptide 1 (GLP-1) medicines has moved from warning signals to visible enforcement. On 23 May 2026, the South African Health Products Regulatory Authority (SAHPRA), together with the South African Pharmacy Council (SAPC), announced intensified enforcement action against the unlawful manufacturing and distribution of unregistered GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) medicines containing semaglutide, tirzepatide or a combination of both, promoted for weight loss.

Healthcare & Pharmaceuticals

3 min read

15 Oct 2025

by Allan Hannie and Phetha Mchunu

BEE and Public Interest in Merger Control

CDH is pleased to announce the launch of its new podcast series, Clause & Effect, which provides listeners with an informed and engaging view into the intersection of business and law.

Corporate & Commercial Law

27:39 Minutes

15 Oct 2025

by Allan Hannie and Phetha Mchunu

Clause & Effect Podcast Series | BEE and Public Interest in Merger Control

CDH is pleased to announce the launch of its new podcast series, Clause & Effect, which provides listeners with an informed and engaging view into the intersection of business and law.

Corporate & Commercial Law

26:13 Minutes

4 Feb 2026

by Allan Hannie, Akhona Mgwaba and Keanan Wheeler

Proposed revisions to the ESD Scorecard in the draft B-BBEE Code amendments

On 29 January 2026, the Department of Trade, Industry and Competition (DTIC) published several significant draft amendments (Draft Amendments) to the Generic Codes of Good Practice on Broad-Based Economic Empowerment (Generic Codes) in terms of section 9(5) of the Broad-Based Black Economic Empowerment Act 53 of 2003 (Act).

Black Economic Empowerment (BEE)

6 min read